Small Nucleic Acid Normalization via Degenerate Primer Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for isolating small nucleic acid species, such as siRNA and miRNA, face challenges due to low abundance and cloning biases, limiting the identification and analysis of these molecules, which are crucial for understanding gene regulation and disease mechanisms.

Innovation Solution

The method involves ligating adapters to small nucleic acids, followed by amplification using primers with degenerate sequences to generate a normalized population, allowing for the identification of specific nucleic acid species through sequencing and cloning.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional cloning methods are used to isolate small nucleic acid species, then the process is simple and widely applicable, but the representation of low-abundance species is biased and distorted

Engineering Contradiction:
Improvecloning method applicabilityVSAvoidspecies abundance representation
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent applies preliminary action by performing adapter ligation to small nucleic acids before amplification. This preliminary step ensures that all species, including low-abundance ones, are tagged with adapters that enable their subsequent detection and normalization during PCR amplification, preventing their loss in conventional cloning processes.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the parameter of primer concentration during PCR amplification by using formulated relative concentrations of primers. This parameter change enables normalization of the population, adjusting the representation of different small nucleic acid species so that low-abundance species are not lost in the amplification process.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If conventional cloning procedures are used, then the workflow is straightforward, but cloning biases cause overabundance of certain clones relative to others

Engineering Contradiction:
Improvecloning workflow simplicityVSAvoidclone abundance distribution
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent implements feedback by using degenerate sequences in primers that can adapt to different adapter sequences. This feedback mechanism ensures that the amplification process accounts for variations in the starting population, adjusting primer binding to normalize the representation of different clones and prevent bias toward certain sequences.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent applies parameter changes by formulating relative concentrations of primers based on the expected abundance of different small nucleic acid species. This allows the amplification process to compensate for initial biases and achieve a normalized population where each species is represented proportionally.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If conventional isolation methods are used, then the process is simple, but the identification limit is reached for certain species like miRNA

Engineering Contradiction:
Improveisolation process simplicityVSAvoidspecies identification capability
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent applies preliminary action by ligating adapters to small nucleic acids before amplification. This step is crucial for species like miRNA that are difficult to isolate, as the adapter ligation enables subsequent PCR amplification and sequencing, pushing the identification limit beyond what conventional methods can achieve.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses adapters as intermediaries between the small nucleic acids and the amplification/sequencing process. These adapters facilitate the detection and identification of low-abundance species by providing a universal binding site that enables their incorporation into the amplification workflow, overcoming the limitations of direct conventional isolation methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the normalization of small nucleic acid populations, overcoming the limitations of conventional cloning methods by enhancing the representation of low-abundance species and facilitating their identification and analysis.

Implementation Method 1

ligating adapters to one or both ends of at least some of the small nucleic acids to form a multiplicity of adapter-modified molecules

Methodology Applied
Scientific EffectLigation: Chemical Bonding

Implementation Method 2

amplifying the multiplicity of adapter-modified molecules with a multiplicity of primers to generate extension products

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS8741569B2Methods for normalizing and for identifying small nucleic acids
Publication Date: 2014.06.03 APPLIED BIOSYSTEMS LLC
  • US8741569B2 patent drawing
  • US8741569B2 patent drawing
  • US8741569B2 patent drawing

AI summary

The present teachings are generally directed to methods for normalizing at least one species of small nucleic acid that is present in a population of small nucleic acid species, wherein the relative concentration of at least one small nucleic acid species is substantially greater than the relative concentration of at least one other small nucleic acid species in the population. At least one small nucleic acid species is normalized using a multiplicity of primers comprising degenerate sequences. In some embodiments, a small nucleic acid species is identified by inserting at least part of an extension product from a normalized population into a vector and subsequently sequencing the insert. In some embodiments, a small nucleic acid species is identified by determining the sequence of at least part of an extension product.